Atrial remodelling and atrial fibrillation self-sustaining: the role of circulating circDGCR8
Cardiovascular Research · 08.07.2025 · 121 (7) · 1036-1051
DOI: 10.1093/cvr/cvaf060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 08.05.2025. Verfasst von Yuanfeng Gao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Heart Center & Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, No. 8, Gongti South Road, Chaoyang Dist…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Atrial Remodeling, RNA, Circular, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Beijing Hospitals Authority Youth Programme, Beijing Hospitals Authority Clinical medicine Development of special funding support.
Abstract (Originalsprache)
Aims
The prediction of atrial fibrillation (AF) progression and post-ablation recurrence is currently based on empirical estimates, leading to suboptimal predictive accuracy. This study investigates whether atrial remodelling, a key factor in the severity of atrial cardiomyopathy, could serve as a shared substrate influencing both AF progression and recurrence. We aimed to identify circular RNAs (circRNAs) associated with atrial remodelling and to evaluate their ability to predict AF progression and recurrence. Methods and results We assessed the differential expression of plasma circRNAs between paroxysmal (PAF) and persistent AF (PsAF) patients using microarray analysis. Selected candidate circRNAs were validated through qPCR following rigorous statistical and bioinformatics analysis. circDGCR8 was consistently found to be up-regulated in PsAF compared with PAF patients. Additionally, circDGCR8 was significantly up-regulated in human atrial fibroblasts treated with angiotensin II (AngII). Gain- and loss-of-function studies suggested that circDGCR8 could promote atrial remodelling at cellular level by enhancing collagen production and fibroblast proliferation. Overexpression of circDGCR8 in human cardiac fibroblasts significantly altered the gene expression spectrum, impacting pathways including IL-17 signalling and TNF signalling. Moreover, circDGCR8 levels were positively correlated with atrial fibrosis, as indicated by increased percentages of low voltage zones. The predictive value of circDGCR8 was evaluated in two cohorts: (i) PAF patients monitored for 36 months with progression to PsAF as the endpoint, and (ii) AF patients who underwent radiofrequency ablation followed for 12 months to assess recurrence. In both cohorts, higher level of circDGCR8 was associated with increased risks of AF progression and post-ablation recurrence.
Conclusion
Our results suggest that circDGCR8, associated with atrial remodelling, holds potential as a predictive biomarker for both AF progression and post-ablation recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heart Center & Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, No. 8, Gongti South Road, Chaoyang District, Beijing 100020, China.
- Central Laboratory, Peking University School and Hospital of Stomatology, National Engineering Laboratory for Digital and Material Technology of Stomatology, Beijing Key Laboratory of Digital Stomatology, No. 22, Zhongg…
- Cardiometabolic Genomics Program, Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, 622 West 168th Street PH-10 Suite 305, New York, NY 10032, USA.
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, 38 Xueyuan Road, Haidian District, Beijing 100191, China.
- Department of Human Genetics, University of Michigan, 4909 Buhl Building, 1241 E. Catherine St., Ann Arbor, MI 48109-5618, USA.
- Molecular Biology Institute, David Geffen School of Medicine, University of California, Gonda 4335A, 695 Charles E. Young Drive South, Los Angeles, CA 90095, USA.
Förderung
- NHLBI NIH HHS
- Beijing Hospitals Authority Youth Programme
- Beijing Hospitals Authority Clinical medicine Development of special funding support
- National Natural Science Foundation of China
- Capital's Funds for Health Improvement and Research
- Open funding for Key Laboratory of Medical Engineering in Cardiovascular Disease Research, Ministry of Education
- NIH
Zitieren
APA
Gao, Y., Dong, Y., Jiang, N., Zhang, H., Liu, Z., Wang, Q., Fu, Y., Li, J., Li, Z., Pan, H., Zheng, X., Zhan, L., Yang, X., Xu, L., & Chen, M. (2025). Atrial remodelling and atrial fibrillation self-sustaining: the role of circulating circDGCR8. Cardiovascular Research, 121(7), 1036-1051. https://doi.org/10.1093/cvr/cvaf060
Vancouver
Gao Y, Dong Y, Jiang N, Zhang H, Liu Z, Wang Q, et al. Atrial remodelling and atrial fibrillation self-sustaining: the role of circulating circDGCR8. Cardiovascular Research. 2025;121(7):1036-1051. doi:10.1093/cvr/cvaf060
BibTeX
@article{Gao2025,
author = {Gao, Yuanfeng and Dong, Ying and Jiang, Nan and Zhang, Hanrui and Liu, Zheng and Wang, Qianhui and Fu, Yuan and Li, Jing and Li, Zhiqing and Pan, Huize and Zheng, Xianing and Zhan, Lingyu and Yang, Xinchun and Xu, Li and Chen, Mulei},
title = {Atrial remodelling and atrial fibrillation self-sustaining: the role of circulating circDGCR8},
journal = {Cardiovascular Research},
year = {2025},
volume = {121},
number = {7},
pages = {1036--1051},
doi = {10.1093/cvr/cvaf060}
}
EUVIMED